10x Genomics (TXG) Revenue Growth (3y) (2021 - 2026)
Powered by 
Analysis
10x Genomics (TXG) Revenue Growth (3y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 226.93 Bn | 222.99 Bn | 8.34 Bn | 3.92% |
| 2 | Danaher | 145.94 Bn | 141.60 Bn | 3.61 Bn | 1.95% |
| 3 | Agilent Technologies | 42.55 Bn | 40.79 Bn | 1.04 Bn | 3.95% |
| 4 | Illumina | 32.95 Bn | 31.78 Bn | 770.00 Mn | -0.48% |
| 5 | Revvity | 14.53 Bn | 13.51 Bn | 416.87 Mn | 0.96% |
| 6 | Bio-Techne | 11.31 Bn | 11.04 Bn | 211.39 Mn | 2.15% |
| 7 | Bio-Rad Laboratories | 10.34 Bn | 8.72 Bn | 345.80 Mn | -1.50% |
| 8 | Repligen | 9.46 Bn | 8.44 Bn | 110.04 Mn | 8.65% |
| 9 | Bruker | 8.91 Bn | 8.73 Bn | 416.00 Mn | 7.13% |
| 10 | 10x Genomics | 8.16 Bn | 7.61 Bn | 112.50 Mn | 0.95% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.95% |
| Mar 31, 2026 | 3.95% |
| Dec 31, 2025 | 2.05% |
| Sep 30, 2025 | 4.37% |
| Jun 30, 2025 | 14.69% |
| Mar 31, 2025 | 10.60% |
| Dec 31, 2024 | 4.76% |
| Sep 30, 2024 | 6.57% |
| Jun 30, 2024 | 9.74% |
| Mar 31, 2024 | 10.04% |
| Dec 31, 2023 | 17.91% |
| Sep 30, 2023 | 28.85% |
| Jun 30, 2023 | 50.69% |
| Mar 31, 2023 | 23.15% |
| Dec 31, 2022 | 27.55% |
| Sep 30, 2022 | 28.90% |
| Jun 30, 2022 | 27.10% |
| Mar 31, 2022 | 28.81% |
| Dec 31, 2021 | 41.60% |
| Sep 30, 2021 | 50.70% |